Chemotherapy News and Research

Latest Chemotherapy News and Research

Chemical thumbprint can help determine if tumor is returning or dying

Brain tumor survivors live with the constant worry that their cancer might come back. And even if they have a brain scan every few months to check, doctors often can't tell the difference between new cancer growth and tissue changes related to their treatment with radiation or chemotherapy.

3 May 2004

Developing smart drugs

Dana-Farber Cancer Institute Researchers, sensing an opening in the cancer battle, are mounting a quick thrust to flush out suspected molecular cancer triggers in tumor cells.

30 Apr 2004

Combination of real-time PET and CT is a highly sensitive tool for identifying non-small cell lung cancer

The combination of real-time PET and CT is a highly sensitive tool for identifying non-small cell lung cancer (NSCLC) and can assist in identifying patients whose cancer has not yet spread to lymph nodes, according to results of a study by researchers at Johns Hopkins.

30 Apr 2004

Space technology may help fertility of a woman with cancer

Using technology borrowed from the National Aeronautics and Space Administration (NASA), scientists at the University of Pittsburgh's McGowan Institute for Regenerative Medicine have taken the first steps toward successfully preserving ovarian tissue from rats and mice in culture, including immature egg follicles, according to a study in the current issue of the journal Tissue Engineering.

29 Apr 2004

A new prognostic marker has shown potential to predict recurrence in certain colon cancer patients

In the study, a team of researchers led by Veridex, LLC, a Johnson & Johnson company, used gene expression profiling to identify the new marker – a 23-gene signature – which may predict disease recurrence in patients initially diagnosed with Dukes' B colon cancer.

29 Apr 2004

Scientists identify six genes associated with the most common form of non-Hodgkin's lymphoma

In a paper that will be published on Thursday, April 29, 2004 in the New England Journal of Medicine, a team of scientists from Stanford University and Applied Biosystems, an Applera Corporation business, describe the identification of six genes associated with survival in diffuse large B cell lymphoma (DLBCL), the most common form of non-Hodgkin's lymphoma.

28 Apr 2004

Northern Ireland scientists target bowel cancer treatment

Cancer Research N. Ireland scientists are developing a way for doctors to predict which treatment will be most successful in individual bowel cancer patients.

28 Apr 2004

UK scientists have discovered cancer cells life and death scenario following anti-cancer treatment

CANCER Research UK scientists have discovered how some cancer cells choose to live and others die following anti-cancer treatment, unveiling their findings in the prestigious journal PNAS today.

26 Apr 2004

New cancer drug Tarceva - a breakthrough with significant survival benefit in patients with advanced lung cancer

OSI Pharmaceuticals, Inc., Genentech, Inc., and Roche today announced that a Phase III study of Tarceva™ (erlotinib HCl), an investigational HER1/EGFR-inhibitor agent in previously treated patients with non-small cell lung cancer (NSCLC), met its primary endpoint of improving overall survival, with patients receiving Tarceva™ living longer than those in the placebo arm of the study.

26 Apr 2004

US airport screening in question after health and screening issues

Security screeners at Miami International Airport have become ill for the fourth time in a single month.

25 Apr 2004

Mass spectrometry offers promising diagnostic test for sleeping sickness

Around half a million people a year in sub-Saharan Africa are affected by sleeping sickness (human African trypanosomiasis). The disease is fatal in humans if not treated with chemotherapy; however, adverse effects of drug treatment and an increase in drug resistance underline the importance of establishing an accurate diagnostic test for the disease.

22 Apr 2004

Scientists have discovered an exciting new target in the fight to stop the spread of cancer cells

Scientists at The Institute of Cancer Research have discovered an exciting new target in the fight to stop the spread of cancer cells which could significantly improve treatment by replacing traditional chemotherapy.

20 Apr 2004

Possible breakthrough in AIDS and cancer research

Mayo Clinic researchers have found a way to revive immunity in mice that have abnormal or deficient immune systems. The discovery may lead to a means of restoring immunity to individuals with immunodeficiency diseases such as AIDS and cancer.

20 Apr 2004

New developments in the treatment of pancreatic cancer

A booster dose of a substance already found in the body appears to be safe and non-toxic for the treatment of pancreatic cancer, and shows signs of arresting pancreatic cancer cell growth in patients, Penn State College of Medicine researchers report.

20 Apr 2004

Functional genomics provide improved drug discovery

Functional genomics and proteomics have been quite successful in identifying functions of potential therapeutic targets such as encoded proteins.

20 Apr 2004

Myriad Genetics advances drug for chemotherapy-induced nausea

Myriad Genetics, Inc. today released new data on MPC-4505, its Neurokinin-1 (NK1) receptor antagonist, a drug candidate for chemotherapy-induced nausea and vomiting (emesis). MPC-4505 is a potent, orally bioavailable, CNS-penetrating, highly selective NK1 antagonist.

20 Apr 2004

Bladder cancer is the fourth most common cancer in men and the eighth most common in women

Bladder cancer is the fourth most common cancer in men and the eighth most common in women, according to the National Cancer Institute (NCI). It is expected to be diagnosed in 38,000 men and 15,000 women in the United States in 2003. Treatment is most successful when the disease is caught early.

18 Apr 2004